Search
for
Sort by
Research 121–150 of 454
- Management of CAH during pregnancy
- Obesity and the Polycystic Ovary Syndrome
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Androgen antagonists in androgen target tissues
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS
- Androgen receptor: A promising therapeutic target in breast cancer
- Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride
- Contraceptive use in acne
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- The endocrinology of baldness
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- PCOS: update and diagnostic approach
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Congenital adrenal hyperplasia
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Assessment of anogenital distance as a diagnostic tool in polycystic ovary syndrome
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Polycystic Ovary Syndrome
- Acne vulgaris
- Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children
- The Evaluation and Management of Hirsutism
- Testosterone Therapy in Premenopausal Women
- The role of androgen therapy
- Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome